[Real Estate Information Newspaper] Reporter Kim Soo-yeon = On July 18, Remax Korea (CEO Shin Hee-seong), a global No. 1 real estate company, announced that it had signed a strategic business agreement (MOU) with global medical commercial platform Medius (CEO Park Bo-hyun).
MEDIEUS is a blockchain technologyBan's Medical · It is a healthcare commercial platform.
Medius provides excellent hospitals and customized medical services to domestic and overseas patients based on their personal health information. · It is a platform that provides services to recommend, reserve, and purchase healthcare services and products. We share information based on consumers' medical experiences, build a reputation system for medical service providers, and recommend personalized medical service providers that meet consumers' needs. If you share your data, such as medical receipts, health checkup results, and prescriptions received after visiting the hospital, you can receive compensation with a certain amount of points and use products or services on the platform. As Korea's first open market, the goal is to allow anyone to easily purchase medical information and services as if shopping.
Remax is a real estate franchise company founded in the United States in 1973, and currently has over 140,000 real estate experts active in over 110 countries around the world.
About 400 skilled real estate experts are actively working in Korea, playing a leading role in the domestic real estate market, and are striving to improve customer service by nurturing real estate experts and providing innovative services.
Through this business agreement, Medius plans to provide health checkups and various healthcare services to Remax Korea real estate experts, and Remax will provide various content services to medical institutions and medical staff owned by Medius through real estate sales information held by Remax. will be provided.
In addition, we decided to do our best for new business and mutual growth by combining Remax's real estate sales information and brokerage capabilities with Medius' healthcare data.
| 
